| OrPha Swiss GmbH - Thromboreductin 0.5 mg, Kapseln | | 59031 | | 01 | | Thromboreductin 0.5 mg | | Kapseln | | L01XX35 | | Anagrelide | | 15.04.2010 | | |
| | Composition | | anagrelidum 0.5 mg ut anagrelidi hydrochloridum monohydricum, lactosum monohydricum 93.9 mg, povidonum K 29-32, crospovidonum, cellulosum microcristallinum, magnesii stearas, Kapselhülle: gelatina, aqua, E 171, E 132, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Anagrelide | 0.5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Anagrelide | 0.5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Aqua | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 132 | | color. | | E 171 | | color. | | Gelatina | | Kapselhülle | | Lactose Monohydrate | 93.9 mg | | | Magnesii Stearas | | | | Povidonum K | 29-32 | | | Pro Capsula | | |
| |
| |
|
